In vitro effects of topotecan and ionizing radiation on TRAIL/ Apo2L-mediated apoptosis in malignant glioma

Journal of Neuro-Oncology

Volumn 71, Issue 1, 2005, Pages 19-25

  Ciusani, Emilio ^a   Croci, Danilo ^a   Gelati, Maurizio ^a   Calatozzolo, Chiara ^a   Sciacca, Francesca ^a   Fumagalli, Luisa ^a   Balzarotti, Marco ^a   Fariselli, Laura ^a   Boiardi, Amerigo ^a   Salmaggi, Andrea ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Apoptosis; Glioma; Radiation; Topotecan; TRAIL

Indexed keywords

CYCLOHEXIMIDE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DNA TOPOISOMERASE INHIBITOR; TOPOTECAN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; MALE; PROTEIN EXPRESSION; PROTEIN FAMILY; RADIATION DOSE; RECEPTOR BINDING; SENSITIVITY ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GLIOMA; HUMANS; MEMBRANE GLYCOPROTEINS; NERVOUS SYSTEM NEOPLASMS; RADIATION, IONIZING; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOPOTECAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14044267654     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-9180-4     Document Type: Article

References (28)

1. WR Shapiro JR Shapiro 1998 Biology and treatment of malignant glioma Oncology 12 233-240
2. A Ashkenazi RC Pai S Fong S Leung DA Lawrence SA Masters C Blackie L Chang AE McMurtrey A Herbert L DeForge IL Koumenis D Lewis L Harris J Bussiere H Koeppen Z Shahrokh RH Schwall 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 155-162 1:CAS:528:DyaK1MXkslSmsbw%3D 10411544
3. H Walczak RE Miller K Ariail B Gliniak TS Griffith M Kubin W Chin J Jones A Woodward T Le C Smith P Smolak RG Goodwin CT Rauch JC Schuh DH Lynch 1999 Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Med 5 157-163
4. A Ashkenazi 2002 Targeting death and decoy receptors of the tumor necrosis factor superfamily Nat Rev Cancer 2 420-430
5. T Yamanaka K Shiraki K Sugimoto M Ito K Takase M Moriyama T Nakano A Suzuki 2000 Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines Hepatology 32 482-490
6. M Nagane G Pan JJ Weddle VM Dixit WK Cavenee HJ Su Huang 2000 Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo Cancer Res 60 847-853 1:CAS:528:DC%2BD3cXhs1Siu7w%3D 10706092
7. Y Mizutani M Nakao O Ogawa O Yoshida B Bonavida T Miki 2001 Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apotosis inducing ligand mediated apoptosis by cisplatin and carboplatin J Urol 165 263-270
8. Y Arizono H Yoshikawa H Nagamuna Y Hamada Y Nakajima K Tasaka 2003 A mechanism of resistance to TRAIL/Apo 2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by gentoxic agents Br J Cancer 88 298-306 10.1038/sj.bjc.6600666 1:CAS:528:DC%2BD3sXhsV2rt70%3D 12610517
9. E Ciusani P Perego N Carenini E Corna F Facchinetti A Boiardi A Salmaggi F Zunino 2002 Fas/CD95-mediated apoptosis in human glioblastoma cells: A target for sensitisation to topoisomerase I inhibitors Biochem Pharmacol 63 881-887
10. MS Sheikh TF Burns Y Huang GS Wu S Amundson KS Brooks AJ Fornace Jr WS el-Deiry 1998 p53 dependent and independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alfa Cancer Res 58 1593-1598
11. SN Sanghavi MN Needle MD Krailo JR Geyer J Ater MP Mehta 2003 A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: First report of the Children's Cancer Group-0952 Neuro-oncology 5 8-13
12. B Gong A Almasan 2000 Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells Cancer Res 60 5754-5760
13. HK Rooprai A Merzak P Bullok GJ Pilkington 1997 Establishment and characterization of two paediatric brain tumor cell line in vitro Anticancer Res 17 4127-4134
14. S Spiegl-Kreinecker J Buchtroithner L Elbling E Steiner G Wurm A Bodenteich J Fischer M Micksche W Berger 2002 Expression and functional activity of the ABC-transporter protein P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes J Neuro-Oncol 57 27-36
15. F Spinozzi E Agea O Bistoni A Travetti G Migliorati R Moraca I Nicoletti C Riccardi FP Paoletti R Vaccaro A Bertotto 1995 T lymphocytes bearing the gamma delta T cell receptor are susceptible of steroid-induced programmed cell death Scand J Immunol 41 504-508
16. HJ Guchelaar A Vermes I Vermes C Haanen 1997 Apoptosis: Molecular mechanisms and implications for cancer chemotherapy Pharm Word Sci 19 119-125
17. LA Tartaglia DV Goeddel 1992 Two TNF receptors Immunol Today 13 151-153 10.1016/0167-5699(92)90116-O 1:CAS:528:DyaK38XltV2nu7k%3D 1322675
18. S Nagata 1997 Apoptosis by death factors Cell 88 355-365 10.1016/ S0092-8674(00)81874-7
19. D Lawrence Z Shahrokh S Marsters K Achilles D Shih B Mounho K Hillan K Torpal L DeForge P Schow I Hooley S Sherwood R Pai S Leung L Khan B Gliniak J Bussiere CA Smith SS Strom S Kelley JA Fox D Thomas A Ashkenazi 2001 Differential hepatocyte toxicity to recombinant Apo2L/ TRAIL versions Nat Med 7 383-385
20. C Hao F Beguinot G Condorelli A Trencia EG Meir Van VW Yong IF Parney WH Roa KC Petrok 2001 Induction and intracellular regulation of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells Cancer Res 61 1162-1170
21. TA Röhn B Wagenknecht W Roth U Naumann E Gulbins PH Krammer H Walczak M Weller 2001 CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release Oncogene 20 4128-4137
22. MJ Knight CD Riffkin AM Muscat DM Ashley CJ Hawkins 2001 Analysis of FasL and TRAIL induced apoptosis pathwas in glioma cells Oncogene 20 5789-5798
23. F Schmidt J Rieger J Wischhusen U Naumann M Weller 2001 Glioma sensitivity to topotecan: The role of p53 and topotecan-induced DNA damage Eur J Pharmacol 412 21-25
24. GS Wu TF Burns ER McDonald III W Jiang R Meng ID Kranz G Kao DD Gan JY Zhou R Muschel RS Hamilton NB Spinner S Markovitz G Wu W el-Deiry 1997 KILLED/DR5 is a DNA damage inducible p-53 regulated death receptor gene Nat Genet 7 141-143
25. AM Chinnaiyan U Prasad S Shancar DA Hamstra M Shanaiah TL Chenevert BD Ross A Rehemtulla 2000 Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proc Natl Acad Sci 97 1754-1759 10.1073/pnas.030545097 1:CAS:528:DC%2BD3cXhsFCrt70%3D 10677530
26. R Di Pietro P Sacchiero R Rana D Gibellini G Visani K Bernis L Zamai 2001 Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1 Blood 97 2596-2603
27. MR Kim JL Lee MT Park YJ Chu YJ Jang CM Kang HS Kim CK Cho YS Lee HY Jeong SJ Lee 2001 Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells FEBS Letters 505 179-184
28. C Belka B Schmidt P Marini E Durand J Rudner H Faltin M Bamb K Shulze-Osthoff W Budach 2001 Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL Oncogene 20 2190-2196